Pergolide for Mules: Uses, PPID Treatment & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Pergolide is a prescription dopamine agonist used in equids to help control the clinical signs of pituitary pars intermedia dysfunction (PPID), often called equine Cushing’s disease. In the United States, the FDA-approved equine brand is Prascend. While the label is written for horses, your vet may also use pergolide in mules because mules are equids and PPID management principles are generally similar across horses, donkeys, and mules.

Pergolide does not cure PPID. Instead, it helps reduce abnormal hormone output from the pituitary gland, which can improve quality of life and lower the risk of complications tied to the disease. Many mules with PPID need lifelong treatment, along with hoof care, diet changes, and regular monitoring.

Because mules can differ from horses in body condition, metabolism, and how they show pain or illness, dosing and follow-up should be individualized. Your vet may use body weight, ACTH testing, season, appetite, and clinical response to decide whether the current plan is working.

Pergolide is used primarily to manage PPID in mules. Vets reach for it when a mule has compatible signs such as a long or delayed-shedding coat, topline muscle loss, lethargy, increased drinking or urination, abnormal sweating, recurrent infections, or laminitis concerns. In equids, pergolide is considered the main medication for controlling PPID-related clinical signs.

Treatment is usually part of a broader plan, not a stand-alone fix. Your vet may pair pergolide with seasonal bloodwork, dental care, hoof support, weight management, and a forage-first diet that fits the mule’s insulin and laminitis risk. If insulin dysregulation is also present, that may need separate management.

Some mules improve within a few weeks, but full clinical response can take longer. Coat changes, energy level, and comfort often improve gradually, while lab values may be rechecked after your mule has been on a stable dose long enough for a meaningful response.

Pergolide dosing in equids is typically started low and adjusted to effect under your vet’s guidance. The labeled equine starting dose for pergolide tablets is 2 mcg/kg by mouth once daily. For a 500 kg equid, that equals 1 mg once daily. Many vets use this as a practical starting point, then adjust based on clinical signs and follow-up testing.

If a mule develops appetite loss or other signs of dose intolerance, your vet may recommend a slower introduction, a temporary dose reduction, or gradual titration back upward. In the product information for Prascend, dose adjustments are generally made in 2 mcg/kg increments, and the labeled total daily dose should not exceed 4 mcg/kg/day unless your vet has a specific reason to use a different plan.

Pergolide is usually given by mouth once daily. Tablets may be hidden in a small amount of feed if your vet says that is appropriate, but it is important to make sure the full dose is actually swallowed. Because PPID treatment is long term, consistency matters. Do not stop the medication or change the dose on your own, especially if your mule has a history of laminitis or worsening seasonal signs.

The most common side effect reported with pergolide in equids is decreased appetite. Some animals also seem dull, less interested in feed, or mildly depressed when first starting treatment or after a dose increase. Horse caregivers sometimes call this the “pergolide veil.” In many cases, these signs improve after the animal adjusts, especially if the dose is introduced more gradually.

Other possible side effects include diarrhea, loose manure, mild colic signs, weight loss, and lethargy. If your mule stops eating, seems painful, becomes dehydrated, or shows worsening weakness, see your vet promptly. A mule that is already thin, older, or prone to laminitis may need closer monitoring during the first few weeks of therapy.

See your vet immediately if your mule has severe inappetence, repeated colic signs, marked diarrhea, collapse, or a sudden decline in hoof comfort. Those signs may reflect dose intolerance, another illness, or progression of the underlying endocrine disease rather than the medication alone.

Pergolide can interact with other drugs that affect dopamine signaling. In general, medications that block dopamine may reduce pergolide’s effect, while other dopamine-active drugs can change how your mule responds. This matters most when your vet is balancing endocrine treatment with reproductive, neurologic, or gastrointestinal medications.

One practical example in equids is domperidone, a dopamine antagonist used in some reproductive situations. Because it works in the opposite direction, it may counteract pergolide’s intended effect. Your vet will also want to know about any compounded medications, supplements marketed for “hormone balance,” or recent medication changes.

There is limited mule-specific interaction research, so your vet will usually rely on equine data, your mule’s history, and close monitoring. Before starting pergolide, share a full list of prescription drugs, over-the-counter products, supplements, and feed additives. That helps your vet choose the safest plan and decide what should be monitored after treatment begins.